Literature DB >> 25949881

The correlations between IL-17 vs. Th17 cells and cancer patient survival: a systematic review.

Simone Punt1, Jessica M Langenhoff2, H Putter3, Gert Jan Fleuren1, Arko Gorter1, Ekaterina S Jordanova1.   

Abstract

Both IL-17 and Th17 cells have been ascribed tumor promoting as well as tumor suppressing functions. We reviewed the literature on correlations between IL-17 versus Th17 cells and survival in human cancer, following the PRISMA guidelines. Serum, formalin-fixed, paraffin-embedded (FFPE) tissue and peripheral blood samples were most frequently studied. High IL-17 quantities were correlated with poor prognosis, whereas high Th17 cell frequencies were correlated with improved prognosis. Since Th17 cells are a subpopulation of IL-17+ cells and had a different correlation with prognosis than total IL-17, we substantiate that a distinction should be made between Th17 and other IL-17+ cells.

Entities:  

Keywords:  FFPE, formalin-fixed, paraffin-embedded; IL-17; PBMC, peripheral blood mononuclear cells; RORγ, receptor-related orphan receptor gamma; TNM, tumor node metastasis stage; Th17; cancer; survival; tumor microenvironment

Year:  2015        PMID: 25949881      PMCID: PMC4404813          DOI: 10.4161/2162402X.2014.984547

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  80 in total

1.  Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance.

Authors:  Preetesh Jain; Mohammad Javdan; Franziska K Feger; Pui Yan Chiu; Cristina Sison; Rajendra N Damle; Tawfiqul A Bhuiya; Filiz Sen; Lynne V Abruzzo; Jan A Burger; Andreas Rosenwald; Steven L Allen; Jonathan E Kolitz; Kanti R Rai; Nicholas Chiorazzi; Barbara Sherry
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

2.  Increased circulating Th22 and Th17 cells are associated with tumor progression and patient survival in human gastric cancer.

Authors:  Tao Liu; Liusheng Peng; Peiwu Yu; Yongliang Zhao; Yun Shi; Xuhu Mao; Weisan Chen; Ping Cheng; Tingting Wang; Na Chen; Jinyu Zhang; Xiaofei Liu; Na Li; Gang Guo; Wende Tong; Yuan Zhuang; Quanming Zou
Journal:  J Clin Immunol       Date:  2012-07-04       Impact factor: 8.317

Review 3.  Th17 cells in cancer: help or hindrance?

Authors:  Cailin Moira Wilke; Ilona Kryczek; Shuang Wei; Ende Zhao; Ke Wu; Guobin Wang; Weiping Zou
Journal:  Carcinogenesis       Date:  2011-02-08       Impact factor: 4.944

4.  Circulating IL-17 levels during the peri-transplant period as a predictor for early leukemia relapse after myeloablative allogeneic stem cell transplantation.

Authors:  Byung-Sik Cho; Ji-Young Lim; Seung-Ah Yahng; Sung-Eun Lee; Ki-Seong Eom; Yoo-Jin Kim; Nak-Gyun Chung; Dae-Chul Jeong; Seok Lee; Hee-Je Kim; Seok-Goo Cho; Dong-Wook Kim; Jong-Wook Lee; Woo-Sung Min; Chong-Won Park; Chang-Ki Min
Journal:  Ann Hematol       Date:  2011-09-06       Impact factor: 3.673

5.  Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer.

Authors:  Xiaoqin Wu; Zhirong Zeng; Bin Chen; Jun Yu; Ling Xue; Yuantao Hao; Minhu Chen; Joseph J Y Sung; Pinjin Hu
Journal:  Int J Cancer       Date:  2010-07-01       Impact factor: 7.396

Review 6.  Regulation and function of innate and adaptive interleukin-17-producing cells.

Authors:  Keiji Hirota; Helena Ahlfors; João H Duarte; Brigitta Stockinger
Journal:  EMBO Rep       Date:  2012-02-01       Impact factor: 8.807

7.  Analysis of CD137L and IL-17 expression in tumor tissue as prognostic indicators for gliblastoma.

Authors:  Xiangli Cui; Zhiqin Xu; Zhigang Zhao; Dali Sui; Xiaohui Ren; Qiming Huang; Jiazhen Qin; Limin Hao; Zhenguang Wang; Li Shen; Song Lin
Journal:  Int J Biol Sci       Date:  2013-01-16       Impact factor: 6.580

8.  Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression.

Authors:  Jian Li; George Ka-Kit Lau; Leilei Chen; Sui-sui Dong; Hui-Yao Lan; Xiao-Ru Huang; Yan Li; John M Luk; Yun-Fei Yuan; Xin-yuan Guan
Journal:  PLoS One       Date:  2011-07-07       Impact factor: 3.240

Review 9.  Th17 cells in cancer: the ultimate identity crisis.

Authors:  Stefanie R Bailey; Michelle H Nelson; Richard A Himes; Zihai Li; Shikhar Mehrotra; Chrystal M Paulos
Journal:  Front Immunol       Date:  2014-06-17       Impact factor: 7.561

10.  Intratumor IL-17-positive mast cells are the major source of the IL-17 that is predictive of survival in gastric cancer patients.

Authors:  Xiaosun Liu; Hailong Jin; Geer Zhang; Xianke Lin; Chao Chen; Jianyi Sun; Yu Zhang; Qing Zhang; Jiren Yu
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

View more
  41 in total

1.  Unrelated immunodeficiency states may impact outcomes and immune checkpoint molecule expression in patients with mycosis fungoides: A clinicopathologic case-control study.

Authors:  Shay Warren; Meenal Kheterpal; Patricia L Myskowski; Alison Moskowitz; Steven M Horwitz; Melissa P Pulitzer
Journal:  J Am Acad Dermatol       Date:  2017-11-10       Impact factor: 11.527

2.  rPAC: Route based pathway analysis for cohorts of gene expression data sets.

Authors:  Pujan Joshi; Brent Basso; Honglin Wang; Seung-Hyun Hong; Charles Giardina; Dong-Guk Shin
Journal:  Methods       Date:  2021-10-07       Impact factor: 3.608

3.  Integrated Multi-Omics Data Analysis Reveals Associations Between Glycosylation and Stemness in Hepatocellular Carcinoma.

Authors:  Peiyan Liu; Qi Zhou; Jia Li
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

4.  The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma Prognosis.

Authors:  Matjaz Vogelsang; Carlos N Martinez; Justin Rendleman; Anuj Bapodra; Karolina Malecek; Artur Romanchuk; Esther Kazlow; Richard L Shapiro; Russell S Berman; Michelle Krogsgaard; Iman Osman; Tomas Kirchhoff
Journal:  Clin Cancer Res       Date:  2016-01-05       Impact factor: 12.531

5.  Th9 and Th17 cells: the controversial twins in cancer immunity.

Authors:  Chi Yan; Ann Richmond
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

6.  Recruitment and significance of Th22 cells and Th17 cells in malignant ascites.

Authors:  Xian-Wen Yang; Hai-Xing Jiang; Ronge Lei; Wei-Shun Lu; Shi-Hui Tan; Shan-Yu Qin
Journal:  Oncol Lett       Date:  2018-08-16       Impact factor: 2.967

Review 7.  Immune crosstalk in cancer progression and metastatic spread: a complex conversation.

Authors:  Hannah Garner; Karin E de Visser
Journal:  Nat Rev Immunol       Date:  2020-02-05       Impact factor: 53.106

8.  Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers.

Authors:  David H Peng; B Leticia Rodriguez; Lixia Diao; Pierre-Olivier Gaudreau; Aparna Padhye; Jessica M Konen; Joshua K Ochieng; Caleb A Class; Jared J Fradette; Laura Gibson; Limo Chen; Jing Wang; Lauren A Byers; Don L Gibbons
Journal:  Nat Commun       Date:  2021-05-10       Impact factor: 14.919

9.  The Immune Landscape of Cancer.

Authors:  Vésteinn Thorsson; David L Gibbs; Scott D Brown; Denise Wolf; Dante S Bortone; Tai-Hsien Ou Yang; Eduard Porta-Pardo; Galen F Gao; Christopher L Plaisier; James A Eddy; Elad Ziv; Aedin C Culhane; Evan O Paull; I K Ashok Sivakumar; Andrew J Gentles; Raunaq Malhotra; Farshad Farshidfar; Antonio Colaprico; Joel S Parker; Lisle E Mose; Nam Sy Vo; Jianfang Liu; Yuexin Liu; Janet Rader; Varsha Dhankani; Sheila M Reynolds; Reanne Bowlby; Andrea Califano; Andrew D Cherniack; Dimitris Anastassiou; Davide Bedognetti; Younes Mokrab; Aaron M Newman; Arvind Rao; Ken Chen; Alexander Krasnitz; Hai Hu; Tathiane M Malta; Houtan Noushmehr; Chandra Sekhar Pedamallu; Susan Bullman; Akinyemi I Ojesina; Andrew Lamb; Wanding Zhou; Hui Shen; Toni K Choueiri; John N Weinstein; Justin Guinney; Joel Saltz; Robert A Holt; Charles S Rabkin; Alexander J Lazar; Jonathan S Serody; Elizabeth G Demicco; Mary L Disis; Benjamin G Vincent; Ilya Shmulevich
Journal:  Immunity       Date:  2018-04-05       Impact factor: 43.474

10.  Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma.

Authors:  Faridoddin Mirshahi; Hussein F Aqbi; Madison Isbell; Saeed H Manjili; Chunqing Guo; Mulugeta Saneshaw; Dipankar Bandyopadhyay; Mikhail Dozmorov; Archit Khosla; Katy Wack; Oscar M Carrasco-Zevallos; Michael O Idowu; Xiang-Yang Wang; Arun J Sanyal; Masoud H Manjili
Journal:  Cell Rep       Date:  2022-03-01       Impact factor: 9.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.